Levine Jon R 4

What Happened
Jon R. Levine, reported as a 10% owner of Marimed, had 23,333 restricted stock units (RSUs convert/vest) convert into common stock on March 7, 2026. The filing shows 23,333 shares acquired at $0.00 (RSU vesting). To satisfy tax withholding, 8,085 of the shares were surrendered/withheld at $0.08 per share (reported total $679). The filing also shows a related derivative disposition of 23,333 shares (reported at $0.00).

Key Details

• Transaction date: March 7, 2026 (filed March 9, 2026) — Form 4 appears timely (filed within the usual 2-business-day window).
• Primary entries reported: 23,333 shares acquired via RSU conversion (code M, $0.00); 8,085 shares disposed for tax withholding (code F, $0.08, $679 reported); a related derivative disposition of 23,333 shares (code M, $0.00).
• Footnotes of note: F1 — RSUs convert one-for-one to common stock; F2 — shares withheld to satisfy tax withholding; F3 — some shares are held in trust for spouse/children and the reporting person disclaims beneficial ownership; F4 — these RSUs were granted 3/7/2023 and no unvested RSUs remain under that grant.
• Shares owned after the transactions are not provided in the excerpt summarized here.

Context

• This was a vesting/conversion of RSUs (not a cash purchase). The $0.00 per-share entries reflect RSU conversion rather than exercising stock options for a cash price.
• The 8,085-share disposition is a standard tax-withholding surrender (a cashless-withholding routine), not an open-market sale.
• As a reported 10% owner, Levine is a significant shareholder; disclosures are regulatory reporting of ownership/vesting events rather than an explicit buy/sell signal about company prospects.